ALS drug wins FDA approval despite questionable data
newsare.net
WASHINGTON, DC (AP) — A much-debated drug for Lou Gehrig's disease won US approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines. The...ALS drug wins FDA approval despite questionable data
WASHINGTON, DC (AP) — A much-debated drug for Lou Gehrig's disease won US approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines. The... Read more